Tracked deals
4
4 tracked deals across 2024-2025.
München, Bavaria, Germany
Munich-headquartered life sciences consulting platform combining specialist firms to support pharmaceutical and biotech clients across Europe and the U.S. Services span real-world evidence, health economics and market access, regulatory affairs, pharmacovigilance, and data, AI and scientific computing. The group reports 500+ professionals across 14 countries.
Tracked deals
4
4 tracked deals across 2024-2025.
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Addon
3 addon · 1 buyout
Last 2 years
Supporting Data
athagoras has acquired DiaMed Beratungsgesellschaft für pharmazeutische Unternehmen mbH, a German consultancy specialising in Regulatory Affairs and Pharmacovigilance, to strengthen its RA/PV capabilities and expand local capacity in Germany. The deal adds DiaMed's experienced team to athagoras' European life‑sciences services platform and complements existing operations including CSO Pharma and S-cubed.
ATHAGORAS Holding GmbH (athagoras group) has acquired UK-based regulatory affairs and quality assurance consultancy S-cubed Ltd and integrated it into the athagoras platform. The deal expands athagoras’s life-sciences service capabilities in regulatory affairs, quality assurance and biometrics to support broader European and global client coverage.
Athagoras, a Munich-based life sciences consulting platform, has acquired Quantify Research, a Nordic-headquartered specialist in real-world evidence (RWE), health economics (HEOR) and market access. The acquisition expands Athagoras' RWE and market access capabilities and strengthens its presence in the Nordic region and Asia-Pacific to better serve global pharmaceutical clients.
ATHAGORAS Group has acquired CSO Pharma Consulting GmbH to expand and internationalize its pharmacovigilance, medical affairs, quality management and GDP consulting capabilities across the pharma and healthcare sectors. The deal adds a specialized provider of PV and regulatory support to ATHAGORAS' life‑sciences services platform while CSO retains focus on organic growth and continuity for clients and employees.
Turn tracked acquisition activity into an outreach-ready buyer list.